| 1 |
35040015 | Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation. | 2022 Apr |
1 |
| 2 |
35525272 | The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification. | 2022 May 5 |
1 |
| 3 |
31391090 | Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans. | 2019 Aug 7 |
1 |
| 4 |
29686391 | Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs). | 2018 Apr 23 |
2 |
| 5 |
29752409 | Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus α-synuclein and β-amyloid aggregates. | 2018 Jul 6 |
1 |
| 6 |
28387673 | Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease. | 2017 |
1 |
| 7 |
25842390 | HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology. | 2015 May |
3 |
| 8 |
26126828 | Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake. | 2015 Aug 28 |
1 |
| 9 |
15211644 | An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's disease. | 2004 Jul 1 |
1 |
| 10 |
12878436 | Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders. | 2003 Aug |
1 |
| 11 |
10378377 | Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. | 1999 Jun |
3 |
| 12 |
9108114 | Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. | 1997 Apr 15 |
1 |
| 13 |
8849730 | Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. | 1996 Oct 10 |
1 |